$ASPN News

Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $5

Aspen Aerogels: Green Shoots Fail To Truly Impress Investors

Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot

Aspen Aerogels, Inc. 2026 Q2 - Results - Earnings Call Presentation

Aspen Aerogels, Inc. (ASPN) Q2 2026 Earnings Call Transcript

Aspen Aerogels (NYSE:ASPN) Jumps on Q2 Revenue Beat and Raised Guidance

Aspen Aerogels Sees Q3 GAAP EPS $(0.11)-$(0.07) vs $(0.14) Est; Sees Sales $65.000M-$80.000M vs $56.933M Est

Aspen Aerogels, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call

How The Aspen Aerogels (ASPN) Investment Story Is Shifting With Mixed Analyst Views

Aspen Aerogels Begins Staged Restart of East Providence Facility

Aspen Aerogels (ASPN) Price Target Increased by 51.19% to 6.48

Aspen Aerogels, Inc. 2026 Q1 - Results - Earnings Call Presentation

Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $4

Aspen Aerogels Q1 Earnings Call Highlights

Aspen Aerogels, Inc. Q1 2026 Earnings Call Summary

Aspen Aerogels (ASPN) Q1 2026 Earnings Transcript

Aspen Aerogels (NYSE:ASPN) Rallies on Strong Cash Position and Above-Consensus Q2 Guidance Despite Slight Earnings Miss and Facility Incident

Aspen Aerogels, Inc. (ASPN) Q1 2026 Earnings Call Transcript

Aspen Aerogels Sees Q2 GAAP EPS $(0.24)-$(0.17) vs $(0.21) Est; Sees Sales $40.000M-$48.000M vs $41.083M Est

Aspen Aerogels Q1 Adj. EPS $(0.28) Misses $(0.26) Estimate, Sales $37.884M Beat $37.388M Estimate